Agreement Between Patient and Physician Assessment of Eyebrow and Eyelash Hair Loss in Two Phase 3 Trials Evaluating Baricitinib in Patients with Severe Alopecia Areata. J of Skin. 2023;7(6):s295. doi:10.25251/skin.7.supp.295